USP7 and cancer: These inhibitors have little or no effect on cancers with mutant TP53. Selective inhibitors of ubiquitin-specific protease-7 (USP7) such as GNE-6640 and GNE-6776 are also being studied as potential stabilizers of p53 via MDM2 [32].